It's Time to End TB

Tuberculosis (TB) is the world’s deadliest infectious disease, claiming 4,500 lives each day. Since 2000, 54 million lives have been saved, and TB deaths fell by one-third. Despite this, 10 million people still fall ill with TB each year. Swiss TPH is committed to alleviate TB related suffering, working on five continents both on human and animal health from basic research to health system strengthening. #EndTB

Read more

Swiss TPH Spring Symposium

Human Resources for Health

The availability of a well-trained and motivated health workforce remains critical to achieving Universal Health Coverage and the Sustainable Development Goals. Join us on 8 May 2019 for the Swiss TPH Spring Symposium on “Human Resources for Health” in Basel, Switzerland, where we will explore innovations in medical education, vocational training & continuing professional development.

Register Now

Introducing Swiss TPH - Excellence in Global Health

 

Over 800 people from more than 70 nations work at Swiss TPH focusing on infectious and non-communicable diseases, environment, society and health as well as health systems and interventions. They all share the mission to improve population health globally.

New Findings on S. mansoni Life Cycle

For over 50 years, Swiss TPH has researched Schistosomiasis, a neglected tropical disease caused by parasitic flatworms which affects 250 million people globally. A new study details the complex S. mansoni life cycle, contributing to antischistosomal drug discovery.

Photo: Yvette Endriss/Swiss TPH

Read more

One Health in Chad

The Support Project for the Health Districts in Chad (PADS - Programme d'Appui aux Districts Sanitaires au Tchad) aims to strengthen the healthcare system. In order to reach people in remote areas such as nomadic populations, PADS applies a 'One Health' approach taking into account both human and animal health.

PADS is a project of the Swiss Agency for Development and Cooperation.

Click here for French version

MBA in International Health Management

Do you want to become a part of a new generation of leaders in global health?

Swiss TPH’s part-time MBA in International Health Management trains future leaders and managers who want to work in multicultural and transdisciplinary settings.

Learn more about the MBA

A Milestone in the Fight Against Sleeping Sickness

Fexinidazole is the first all-oral drug against sleeping sickness. Swiss TPH contributed significantly to the development of fexinidazole together with DNDi, Sanofi and many others. Since its foundation 75 years ago, Swiss TPH has been researching sleeping sickness. For instance, it was the first to succeed in breeding tsetse flies under laboratory conditions.

Photo: Swiss TPH 1946

More on fexinidazole
25.03.2019 17:15 to 18:00

Anemia as an indirect cause of malaria under-five mortality in sub-Saharan Africa

Lecturer: Isidoros Papaioannou
Location: Swiss TPH, Kilimanjaro
Event category: Advances in Infection Biology, Epidemiology and Global Public Health

01.04.2019 17:15 to 18:00

Mathematical modelling of transmission dynamics of Opisthorchis viverrini

Lecturer: Christine Bürli
Location: Swiss TPH, Kilimanjaro
Event category: Advances in Infection Biology, Epidemiology and Global Public Health

14.02.2019

Swiss-Tanzanian Cooperation: Achieving Universal Health Coverage

In Tanzania, two thirds of the population lacks basic health insurance. The Swiss Agency for Development and Cooperation (SDC) together with Swiss TPH and other partners now... More...

13.02.2019

Besuch des Regierungsrats Basel-Landschaft am Swiss TPH

Am 12. Februar 2019 besuchte der Gesamtregierungsrat Basel-Landschaft das Schweizerische Tropen- und Public Health-Institut (Swiss TPH) und gewann so einen Einblick in die... More...

07.02.2019

Pfizer-Preis geht an zwei Swiss TPH Forscher

Kristina Keitel-Hasler und Niklaus Labhardt, beide Forscher in der Clinical Research Unit am Swiss TPH, erhalten den Pfizer Forschungspreis 2019. Der Forschungspreis der Stiftung... More...

31.01.2019

Scientifically Proven: Air Pollution Harms Health

The debate on air quality standards for ambient air pollutants such as nitrogen oxide, particulate matter and ozone has revived in Germany last week. The International Society for... More...